These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1837690)
1. Indolic and kynurenine pathway metabolites of tryptophan in rat brain: effect of precursor availability on in vivo release. During MJ; Heyes MP; Freese A; Swartz KJ; Matson WR; Markey SP; Martin JB; Roth RH Adv Exp Med Biol; 1991; 294():535-9. PubMed ID: 1837690 [No Abstract] [Full Text] [Related]
2. Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading. During MJ; Freese A; Heyes MP; Swartz KJ; Markey SP; Roth RH; Martin JB FEBS Lett; 1989 Apr; 247(2):438-44. PubMed ID: 2523822 [TBL] [Abstract][Full Text] [Related]
3. Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats. Speciale C; Ungerstedt U; Schwarcz R Neurosci Lett; 1989 Oct; 104(3):345-50. PubMed ID: 2530475 [TBL] [Abstract][Full Text] [Related]
4. Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading. During MJ; Heyes MP; Freese A; Markey SP; Martin JB; Roth RH Brain Res; 1989 Jan; 476(2):384-7. PubMed ID: 2522807 [TBL] [Abstract][Full Text] [Related]
5. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. Swartz KJ; During MJ; Freese A; Beal MF J Neurosci; 1990 Sep; 10(9):2965-73. PubMed ID: 2168940 [TBL] [Abstract][Full Text] [Related]
6. Stable isotope-labeled tryptophan as a precursor for studying the disposition of quinolinic acid in rabbits. Boni RL; Heyes MP; Bacher JD; Yergey JA; Ji XD; Abramson FP; Markey SP Adv Exp Med Biol; 1991; 294():481-4. PubMed ID: 1837688 [TBL] [Abstract][Full Text] [Related]
7. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids. Fukushima T; Umino M; Sakamoto T; Onozato M Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092 [TBL] [Abstract][Full Text] [Related]
8. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279 [TBL] [Abstract][Full Text] [Related]
9. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease. Badawy AA Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600 [TBL] [Abstract][Full Text] [Related]
10. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. Beal MF; Matson WR; Swartz KJ; Gamache PH; Bird ED J Neurochem; 1990 Oct; 55(4):1327-39. PubMed ID: 2144582 [TBL] [Abstract][Full Text] [Related]
11. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558 [TBL] [Abstract][Full Text] [Related]
12. Decreased levels of kynurenic acid in prefrontal cortex in a genetic animal model of depression. Liu XC; Erhardt S; Goiny M; Engberg G; Mathé AA Acta Neuropsychiatr; 2017 Feb; 29(1):54-58. PubMed ID: 27406788 [TBL] [Abstract][Full Text] [Related]
13. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome. Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725 [TBL] [Abstract][Full Text] [Related]
14. Increased L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid concentrations in cerebral cortex following systemic endotoxin administration. Heyes MP; Quearry BJ Adv Exp Med Biol; 1991; 294():559-62. PubMed ID: 1722952 [No Abstract] [Full Text] [Related]
15. [Kynurenine and its metabolites in nervous system diseases]. Vécsei L; Schwab F Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152 [TBL] [Abstract][Full Text] [Related]
16. The effects of kynurenic acid, quinolinic acid and other metabolites of tryptophan on the development of the high pressure neurological syndrome in the rat. Wardley-Smith B; Halsey MJ; Hawley D; Joseph MH Neuropharmacology; 1989 Jan; 28(1):43-7. PubMed ID: 2927579 [TBL] [Abstract][Full Text] [Related]
17. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies. Arnone D; Saraykar S; Salem H; Teixeira AL; Dantzer R; Selvaraj S Neurosci Biobehav Rev; 2018 Sep; 92():477-485. PubMed ID: 29940237 [TBL] [Abstract][Full Text] [Related]
18. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Moroni F Eur J Pharmacol; 1999 Jun; 375(1-3):87-100. PubMed ID: 10443567 [TBL] [Abstract][Full Text] [Related]
19. An expanding range of targets for kynurenine metabolites of tryptophan. Stone TW; Stoy N; Darlington LG Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095 [TBL] [Abstract][Full Text] [Related]
20. Kynurenine production and catabolism in fetal sheep with embolized or nonembolized placentas. Nicholls T; Nitsos I; Smythe G; Walker DW Am J Obstet Gynecol; 2001 Oct; 185(4):988-95. PubMed ID: 11641690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]